BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 12577318)

  • 1. Calcyclin (S100A6) regulates pulmonary fibroblast proliferation, morphology, and cytoskeletal organization in vitro.
    Breen EC; Tang K
    J Cell Biochem; 2003 Mar; 88(4):848-54. PubMed ID: 12577318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S100A6 (calcyclin) deficiency induces senescence-like changes in cell cycle, morphology and functional characteristics of mouse NIH 3T3 fibroblasts.
    Słomnicki LP; Leśniak W
    J Cell Biochem; 2010 Feb; 109(3):576-84. PubMed ID: 20013795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcyclin gene expression is increased by mechanical strain in fibroblasts and lung.
    Breen EC; Fu Z; Normand H
    Am J Respir Cell Mol Biol; 1999 Dec; 21(6):746-52. PubMed ID: 10572072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S100A6 (calcyclin) enhances the sensitivity to apoptosis via the upregulation of caspase-3 activity in Hep3B cells.
    Joo JH; Yoon SY; Kim JH; Paik SG; Min SR; Lim JS; Choe IS; Choi I; Kim JW
    J Cell Biochem; 2008 Mar; 103(4):1183-97. PubMed ID: 17721932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S100A6 - new facts and features.
    Leśniak W; Słomnicki ŁP; Filipek A
    Biochem Biophys Res Commun; 2009 Dec; 390(4):1087-92. PubMed ID: 19891957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P53-dependent suppression of the human calcyclin gene (S100A6): the role of Sp1 and of NFkappaB.
    Króliczak W; Pietrzak M; Puzianowska-Kuznicka M
    Acta Biochim Pol; 2008; 55(3):559-70. PubMed ID: 18714402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S100A6 is a negative regulator of the induction of cardiac genes by trophic stimuli in cultured rat myocytes.
    Tsoporis JN; Marks A; Haddad A; O'Hanlon D; Jolly S; Parker TG
    Exp Cell Res; 2005 Feb; 303(2):471-81. PubMed ID: 15652358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulated expression of S100A6 in human gastric cancer.
    Yang YQ; Zhang LJ; Dong H; Jiang CL; Zhu ZG; Wu JX; Wu YL; Han JS; Xiao HS; Gao HJ; Zhang QH
    J Dig Dis; 2007 Nov; 8(4):186-93. PubMed ID: 17970874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of S100A6 (calcyclin) and its binding partners in intracellular signaling pathways.
    Filipek A; Michowski W; Kuznicki J
    Adv Enzyme Regul; 2008; 48():225-39. PubMed ID: 18155169
    [No Abstract]   [Full Text] [Related]  

  • 10. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
    De Petris L; Orre LM; Kanter L; Pernemalm M; Koyi H; Lewensohn R; Lehtiö J
    Lung Cancer; 2009 Mar; 63(3):410-7. PubMed ID: 18620780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S100A6 binds p53 and affects its activity.
    Słomnicki ŁP; Nawrot B; Leśniak W
    Int J Biochem Cell Biol; 2009 Apr; 41(4):784-90. PubMed ID: 18765292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of S100P in the invasion of pancreatic cancer cells is mediated through cytoskeletal changes and regulation of cathepsin D.
    Whiteman HJ; Weeks ME; Dowen SE; Barry S; Timms JF; Lemoine NR; Crnogorac-Jurcevic T
    Cancer Res; 2007 Sep; 67(18):8633-42. PubMed ID: 17875703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding and functional characteristics of two E-box motifs within the S100A6 (calcyclin) gene promoter.
    Leśniak W; Kuźnicki J
    J Cell Biochem; 2006 Apr; 97(5):1017-24. PubMed ID: 16288473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of S100A6 in pancreatic cancer development and its clinical implication as a diagnostic marker and therapeutic target.
    Ohuchida K; Mizumoto K; Ishikawa N; Fujii K; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
    Clin Cancer Res; 2005 Nov; 11(21):7785-93. PubMed ID: 16278400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanical stretch induces mitochondria-dependent apoptosis in neonatal rat cardiomyocytes and G2/M accumulation in cardiac fibroblasts.
    Liao XD; Wang XH; Jin HJ; Chen LY; Chen Q
    Cell Res; 2004 Feb; 14(1):16-26. PubMed ID: 15040886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FGF-2, IL-1beta and TGF-beta regulate fibroblast expression of S100A8.
    Rahimi F; Hsu K; Endoh Y; Geczy CL
    FEBS J; 2005 Jun; 272(11):2811-27. PubMed ID: 15943814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RhoE inhibits cell cycle progression and Ras-induced transformation.
    Villalonga P; Guasch RM; Riento K; Ridley AJ
    Mol Cell Biol; 2004 Sep; 24(18):7829-40. PubMed ID: 15340047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High nuclear S100A6 (Calcyclin) is significantly associated with poor survival in pancreatic cancer patients.
    Vimalachandran D; Greenhalf W; Thompson C; Lüttges J; Prime W; Campbell F; Dodson A; Watson R; Crnogorac-Jurcevic T; Lemoine N; Neoptolemos J; Costello E
    Cancer Res; 2005 Apr; 65(8):3218-25. PubMed ID: 15833853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exogenous fibroblast growth factors maintain viability, promote proliferation, and suppress GADD45alpha and GAS6 transcript content of prostate cancer cells genetically modified to lack endogenous FGF-2.
    Shain SA
    Mol Cancer Res; 2004 Nov; 2(11):653-61. PubMed ID: 15561781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of cell specific expression of calcyclin (S100A6) in nerve cells and other tissues.
    Leśniak W; Swart GW; Bloemers HP; Kuźnicki J
    Acta Neurobiol Exp (Wars); 2000; 60(4):569-75. PubMed ID: 11200185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.